Effects of peroxisome proliferator-activated receptor α/δ agonists on HDL-cholesterol in vervet monkeys

This publication has 38 references indexed in Scilit:

• Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors
  Endocrinology, 2003
• PPAR agonists in the treatment of atherosclerosis
  Current Opinion in Pharmacology, 2003
• PPARδ is a very low-density lipoprotein sensor in macrophages
  Proceedings of the National Academy of Sciences, 2003
• Effects of peroxisome proliferator‐activated receptor‐γ agonists on central nervous system inflammation
  Journal of Neuroscience Research, 2002
• Emerging roles of PPARS in inflammation and immunity
  Nature Reviews Immunology, 2002
• The role of PPARs in atherosclerosis
  Trends in Molecular Medicine, 2002
• PPARs: Transcription Factors Controlling Lipid and Lipoprotein Metabolism
  Annals of the New York Academy of Sciences, 2002
• A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
  Proceedings of the National Academy of Sciences, 2001
• Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates.: Role of Cholesterol and Fatty Acids
  Progress in Lipid Research, 1998
• Compared With Dietary Monounsaturated and Saturated Fat, Polyunsaturated Fat Protects African Green Monkeys From Coronary Artery Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995